Drug Trial Radar · NCT04476303
A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Mar 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
88
Actual
Start
Aug 27, 2020
Primary completion
Nov 23, 2021
Study completion Nov 23, 2021
Sponsor
- Lead sponsor
- BeyondBio Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 20, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 19 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a first in human Phase 1 study to evaluate the safety, tolerability and pharmacokinetics with healthy young and elderly adult male volunteers after receiving single and multiple ascending dose of BEY2153.
Conditions
- Alzheimer's Disease
Interventions
BEY2153Drug
Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum observed plasma concentration (Cmax)Time frame: Day 1 to Day 9
- Area Under the Curve (AUC)Time frame: Day 1 to Day 9
- Apparent terminal elimination half-life (t1/2)Time frame: Day 1 to Day 9
- Apparent clearance (CL/F)Time frame: Day 1 to Day 9
- Apparent volume of distribution (Vz/F)Time frame: Day 1 to Day 9
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul National University Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.